Insmed
INSM
214 hedge funds and large institutions have $3.36B invested in Insmed in 2021 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 74 increasing their positions, 70 reducing their positions, and 14 closing their positions.
164% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 14
56% more call options, than puts
Call options by funds: $3.61M | Put options by funds: $2.31M
11% more funds holding
Funds holding: 193 → 214 (+21)
6% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 70
1% less capital invested
Capital invested by funds: $3.4B → $3.36B (-$38M)
2.86% less ownership
Funds ownership: 107.06% → 104.2% (-2.9%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$17.2M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$16.6M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$10.2M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$34.1M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$15.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.1M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$10.3M |
| 5 |
Morgan Stanley
New York
|
-$9.66M |
INSM Hedge Fund Activity: Q4 2021 in Review
214 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q4 2021, worth a combined $3.36B — down 1.1% from $3.4B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new INSM positions and 14 closed out — a net gain of 23 holders — while 74 added to existing stakes and 70 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $17.2M. The largest seller was Point72 Asset Management, cutting an estimated $34.1M.
- 214 institutional investors held Insmed (INSM) as of Q4 2021, up from 193 in Q3 2021.
- Funds reported $3.36B of Insmed stock for Q4 2021, down 1.1% quarter-over-quarter.
- 37 funds opened new Insmed positions in Q4 2021 and 14 closed out, a net change of +23 holders.
- The largest Insmed buyer in Q4 2021 was AllianceBernstein, an estimated $17.2M added.
- The largest Insmed seller in Q4 2021 was Point72 Asset Management, an estimated $34.1M sold.
Based on aggregated 13F filings for Q4 2021.